11月4日,青岛百洋医药股份有限公司发布公告称,公司与全球生物技术巨头、血液制品领导者杰特贝林(CSL)签订深化合作协议。根据协议,百洋医药将获得杰特贝林旗下人血白蛋白产品安博美在中国大陆地区的独家推广、销售和经销权益。公告提到,百洋医药自 2021 年 3 月与杰特贝林就人血白蛋白产品安博美的零售市场开展合作,本次签署《经销协议》,将合作市场拓展至区域内特定的零售市场、广阔市场、医院市场(君信...
Source Link11月4日,青岛百洋医药股份有限公司发布公告称,公司与全球生物技术巨头、血液制品领导者杰特贝林(CSL)签订深化合作协议。根据协议,百洋医药将获得杰特贝林旗下人血白蛋白产品安博美在中国大陆地区的独家推广、销售和经销权益。公告提到,百洋医药自 2021 年 3 月与杰特贝林就人血白蛋白产品安博美的零售市场开展合作,本次签署《经销协议》,将合作市场拓展至区域内特定的零售市场、广阔市场、医院市场(君信...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.